MedPath

Evaluation of the effect of misoprostol with and without letrozol in missed aborted

Phase 3
Conditions
Missed abortion.
Missed abortion
O02.1
Registration Number
IRCT20190730044380N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
126
Inclusion Criteria

1:Gestational age less than 12 week(confirmed with ultrasonogarphy)
patient with missed abortion (confirmed with ultrasonography)
acceptance of participant
patient age above 18 years old
hemoglobin above 12

Exclusion Criteria

Clinical manifestation or history of adrenal gland impairment
History of any malignancy
History or clinical evidence of any thromboembolic impairment
History of hepatic or renal diseases
Have IUD
History of cardiovascular disease that prescription of misoprostol or letrozol forbidden based on cardiologist opinion.
History of use corticosteroid
Present of classic scar or t shape scar on the uterus
Impairment of coagulation test

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRESENT OF ABORTION:COMPLETE,in complete. Timepoint: every 12 hours. Method of measurement: ultrasonography.
Secondary Outcome Measures
NameTimeMethod
Time interval from induction to abortion. Timepoint: hours. Method of measurement: questionaire.
© Copyright 2025. All Rights Reserved by MedPath